Alok Sonig
CIK 1967368 · EVP,Group President,Pharma · last filed 2025-09-04
Alok Sonig is an EVP,Group President,Pharma who has filed 8 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider had shares withheld for taxes covering $77.1K of BAX on Sep 4, 2025. Current disclosed insider exposure totals $2.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.67M
1
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BAX | EVP,Group President,Pharma | 128,219 | $20.86 | $2.67M | $0 | 8 | 2025-09-04 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-04 | BAX | Tax (F) | −3,191 | -$77.1K | EDGAR |
| 2025-03-10 | BAX | Mixed | +19,127 | -$384.1K | EDGAR |
| 2025-03-05 | BAX | Tax (F) | −1,936 | -$67.5K | EDGAR |
| 2024-09-05 | BAX | Tax (F) | −3,054 | -$115.6K | EDGAR |
| 2024-03-08 | BAX | Grant (A) | +83,353 | $0 | EDGAR |
| 2024-03-05 | BAX | Tax (F) | −1,832 | -$75.1K | EDGAR |
| 2023-09-06 | BAX | Tax (F) | −2,059 | -$83.6K | EDGAR |
| 2023-03-03 | BAX | Grant (A) | +15,428 | $0 | EDGAR |